PharmVar GeneFocus: CYP2C19
Copyright policy )PharmVar GeneFocus: CYP2C19
The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. This GeneFocus provides a comprehensive overview and summary of CYP2C19 and describes how haplotype information catalogued by PharmVar is utilized by the Pharmacogenomics Knowledgebase and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
- Indiana University United States
- University of Puerto Rico, Medical Sciences Campus United States
- Hospital de Clínicas de Porto Alegre Brazil
- UNIVERSITY OF PUERTO RICO
- Purdue University System United States
Cytochrome P-450 CYP2C19, Genotype, Haplotypes, Pharmacogenetics, Knowledge Bases, Genetic Variation, Humans, Genetic variation, Alleles
Cytochrome P-450 CYP2C19, Genotype, Haplotypes, Pharmacogenetics, Knowledge Bases, Genetic Variation, Humans, Genetic variation, Alleles
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).116 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
Citations provided by BIP!Popularity provided by BIP!